Estimating averted COVID-19 cases, hospitalisations, intensive care unit admissions and deaths by COVID-19 vaccination, Italy, January−September 2021

We assessed the impact of COVID-19 vaccination in Italy, by estimating numbers of averted COVID-19 cases, hospitalisations, ICU admissions and deaths between January and September 2021, by age group and geographical macro areas. Timing and speed of vaccination programme implementation varied slightl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sacco, Chiara, Mateo-Urdiales, Alberto, Petrone, Daniele, Spuri, Matteo, Fabiani, Massimo, Vescio, Maria Fenicia, Bressi, Marco, Riccardo, Flavia, Del Manso, Martina, Bella, Antonino, Pezzotti, Patrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619872/
https://www.ncbi.nlm.nih.gov/pubmed/34823637
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.47.2101001
Descripción
Sumario:We assessed the impact of COVID-19 vaccination in Italy, by estimating numbers of averted COVID-19 cases, hospitalisations, ICU admissions and deaths between January and September 2021, by age group and geographical macro areas. Timing and speed of vaccination programme implementation varied slightly between geographical areas, particularly for older adults. We estimated that 445,193 (17% of expected; range: 331,059−616,054) cases, 79,152 (32%; range: 53,209−148,756) hospitalisations, 9,839 ICU admissions (29%; range: 6,434−16,276) and 22,067 (38%; range: 13,571−48,026) deaths were prevented by vaccination.

Ejemplares similares